|
Market Closed -
Nasdaq
23:00:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 8.900 USD | +1.14% |
|
+8.14% | +33.07% |
| 10-06 | Harvard Bioscience, Inc. Announces Creation of Scientific Advisory Board | CI |
| 08-11 | Harvard Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart calendar Harvard Bioscience, Inc.
Upcoming events on Harvard Bioscience, Inc.
| 10/11/2026 | Earnings release - Q3 2026 | |
| 10/11/2026 | Earnings presentation | 16:00 |
Past events on Harvard Bioscience, Inc.
| 11/08/2026 | Earnings presentation | 15:00 |
| 11/08/2026 | Earnings release - Q2 2026 | |
| 02/06/2026 | Annual General Meeting | 17:00 |
| 12/05/2026 | Earnings presentation | 15:00 |
| 12/05/2026 | Earnings release - Q1 2026 | |
| 12/03/2026 | Earnings presentation | 15:00 |
| 12/03/2026 | Earnings release - Q4 2025 | |
| 06/03/2026 | Présentation aux Actionnaires / Analystes | 18:00 |
| 06/03/2026 | Extraordinary General Meeting | 18:00 |
| 06/11/2025 | Earnings presentation | 16:00 |
| 06/11/2025 | Earnings release - Q3 2025 |
Past dividends on Harvard Bioscience, Inc.
| 16/03/2026 | Significant Split/Dividend | 07:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 112 113 -0.36% | 94,1 93,8 0.41% | 86,6 85,9 0.76% | 89,8 | 94,6 |
|
EBITDA Million USD | Released Forecast Spread | 14,6 15,3 -4.9% | 7,20 8,20 -12.24% | 8,08 8,80 -8.17% | 8,70 | 8,50 |
|
EBIT Million USD | Released Forecast Spread | 13,1 13,4 -2.16% | 5,29 5,40 -1.96% | 6,16 4,90 25.78% | 6,30 | 9,00 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,56 -1,55 -64.9% | -11,7 -13,2 11.29% | -57,4 -54,3 -5.78% | -8,75 | -1,95 |
|
Net income Million USD | Released Forecast Spread | -3,42 -1,70 -100.88% | -12,4 -13,3 6.73% | -56,7 -54,0 -5.1% | -8,90 | -2,20 |
|
EPS USD | Released Forecast Spread | -0,80 -0,35 -128.57% | -2,80 -3,05 8.2% | -12,8 -12,1 -5.79% | -1,95 | -0,47 |
| Announcement Date | 07/03/24 | 12/03/25 | 12/03/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 24,6 24,2 1.68% | 21,8 19,2 13.41% | 20,5 18,8 9.07% | 20,6 20,0 2.96% | 23,7 23,1 2.75% | 20,8 21,2 -2.1% | 22,7 21,5 5.95% | 21,8 | 24,5 | 21,8 | 23,7 | 22,6 | 25,5 |
|
EBITDA Million USD | Released Forecast Spread | 2,99 4,00 -25.23% | 0,81 -1,00 181.4% | 1,50 1,00 50% | 1,99 1,50 32.33% | 3,78 3,80 -0.45% | 0,77 1,20 -36.08% | 1,67 1,10 51.55% | 2,00 | 4,20 | 1,50 | 1,30 | 2,20 | 3,50 |
|
EBIT Million USD | Released Forecast Spread | 2,49 2,60 -4.31% | 0,32 -1,70 118.76% | 1,05 -1,90 155% | 1,52 0,00 - | 3,28 2,00 64.1% | 0,23 1,10 -79% | 1,12 1,30 -13.92% | 1,50 | 3,40 | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,59 -0,90 165.56% | -50,8 -4,30 -1081.26% | -2,25 -3,10 27.29% | -1,13 -2,65 57.21% | -3,20 -0,20 -1502% | -3,31 -4,35 23.98% | -2,90 -2,85 -1.61% | -2,30 | -0,20 | -1,30 | -0,60 | 0,30 | 1,50 |
|
Net income Million USD | Released Forecast Spread | 0,02 -0,90 102% | -50,3 -4,30 -1070.7% | -2,28 -3,10 26.39% | -1,23 -2,65 53.55% | -2,85 -0,20 -1323.5% | -3,42 -4,35 21.29% | -2,91 -2,85 -2.11% | -2,30 | -0,20 | -1,30 | -0,60 | 0,20 | 1,20 |
|
EPS USD | Released Forecast Spread | 0,00 -0,20 - | -11,4 -0,95 -1100% | -0,50 -0,70 28.57% | -0,30 -0,60 50% | -0,60 0,00 - | -0,77 -0,95 18.95% | -0,64 -0,63 -2.4% | -0,50 | -0,05 | -0,27 | -0,13 | 0,05 | 0,23 |
| Announcement Date | 12/03/25 | 12/05/25 | 11/08/25 | 06/11/25 | 12/03/26 | 12/05/26 | 11/08/26 | - | - | - | - | - | - |
Past sector events for Harvard Bioscience, Inc.
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HBIO Stock
- Calendar Harvard Bioscience, Inc.
Select your edition
All financial news and data tailored to specific country editions
